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Early and reliable diagnostic test is essential for effective therapy of lung cancer. 
Volatile organic compounds that are characteristic for cancer could serve as valuable 
biomarkers in cancer diagnosis. Both trace analytical and detection dog approaches 
give some evidence for the existence of such biomarkers. In this proof of concept, 
study dogs and trace analysis were implemented in combination to gain more infor-
mation concerning cancer biomarkers. Two dogs were trained to distinguish between 
absorbed breath samples of lung cancer patients and healthy persons and succeeded 
with correct identification of patients with 9/9 and 8/9 and correct negative indications 
from of 8/10 and 4/10 samples from healthy individuals. A recent observational study 
found that breath samples from lung cancer patients showed an increase in 1-butanol, 
2-butanone, 2-pentanone, and hexanal. Synthetic air samples were therefore fortified 
with these compounds and adsorbed to a fleece. Tested against breath samples from 
healthy probands, on presentation to the dogs these synthetic samples provoked an 
indication in three out of four samples. We were able to demonstrate that a combination 
of the natural nose of a dog and a trace analytic technique can be a valuable concept in 
the search for cancer biomarkers.
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inTrODUcTiOn
Lung cancer is one of the most frequent cancer forms in Europe. In 2012, it was the leading type 
of cancer for males and the third most frequent type for females, causing 353.000 deaths in the 
745 billion Europeans (1). Early and accurate diagnostic test is essential for improving the 5-year 
survival rate. There is science-based evidence that dogs are able to identify cancer specific odors in 
breath, blood, and urine samples of cancer patients (2–4). Although some studies reported promis-
ing sensitivities (71–99%) and specificities (78–98%) (5–8), other studies described discouraging 
test characteristics (sensitivities: 3–71% and specificities: 8–53%) and discussed this approach more 
critically (4, 9–12). These controversial results led to the question whether there are specific volatile 
organic compounds (VOCs) that are characteristic for a certain type of cancer cell or for metabolic 
processes in patients suffering from cancer.
Filipiak et al. (13) found that lung cancer cell lines and non-pathogenic cells cultured in vitro 
showed significant differences in the headspace in gas chromatography-mass spectrometry. 
However, in a study by Schallschmidt et al. (14) dogs and honey bees failed to discriminate between 
FigUre 1 | Polyethylene cone for presenting glass tubes to dogs in training and testing. Left picture: perforated plate changed after every contact of a dog’s nose; 
middle picture: glass tube with air sample attached to fleece is inserted into cone. Right picture: dog indicates a cone with a sitting response.
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air from in vitro cultured lung cancer cells and cell-free culture 
medium. Other approaches for biomarker identification used 
in vivo cancer models (15) and resected tumor tissue instead 
of cell cultures (7, 16, 17) which were analyzed with respect to 
differences in VOC profiles of pathogenic and non-pathogenic 
samples.
Volatile organic compounds in breath samples of patients 
suffering from lung cancer have additionally been investigated 
using gas chromatography. Aliphatic aldehydes were among the 
compounds repeatedly suggested to display increased levels in 
exhaled breath of patients (18–20). In addition, aliphatic alde-
hydes have been detected in urine (21) and blood (22) of lung 
cancer patients. Butanol (20, 23) and volatile 2-oxoalkanes (7, 
20, 24) in breath have also repeatedly been associated with lung 
cancer.
The only attempt to combine detection dogs with instrumen-
tal VOC analysis to distinguish between healthy and diseased 
people was reported by Buszewski et al. (7). Dogs’ indication of 
breath odor adsorbed to polypropylene tubes were compared 
with gas chromatography/mass selective detection data of 
VOC in breath samples taken with Tedlar bags from the same 
individuals.
Nevertheless, so far no single VOC or set of VOCs has reached 
clinical relevance for reliable disease recognition with sufficient 
sensitivity and specificity.
The objectives of this study were
 (i)  to set up a system that allows sampling and handling of 
breath for detection dog training, testing in an unbiased 
and reproducible way and the ability to spike samples with 
potential biomarkers;
 (ii) to test if dogs can be trained using this set-up to distin-
guish between breath of lung cancer patients and healthy 
controls;
(iii) to test how these dogs react to synthetic air samples with 
potential volatile biomarkers observed in breath. These 
compounds were 1-butanol, 2-butanone, 2-pentanone, and 
hexanal, which have previously been associated with lung 
cancer (20).
MaTerials anD MeThODs
Material and Technological Developments
The main innovations were the improved fleece tubes 
for breath sampling and the cone-shaped sample-holder 
(Figure 1, patent DE 10 2013 109 901.7) that allowed placing 
and changing the fleece tube easily for detection dog training 
and breath sample testing. The design of the fleece tubes and 
the sample-holders enabled reproducible test runs, efficient 
cleaning of devices between runs and avoided contaminations 
of memory effects.
genuine Breath samples
Probands (patients n  =  30 and healthy controls n  =  30) 
participating in the study were enrolled in the cooperating 
clinic (Evangelische Lungenklinik, Berlin) following a jointly 
developed standard operating procedure for breath sampling, 
documentation of medical status, and ensuring patient ano-
nymity. Breath samples of patients were taken on the first visit 
in the lung clinic for diagnosis, patients were not on any cancer 
treatment. Control persons were matched concerning age, sex 
and smoking habits. Patients and controls were not fasted 
prior to testing. The involvement of probands was approved 
by the Ethics Committee of the Charité, Berlin, Germany, and 
registered as clinical trial with proof-of-concept (EA1/207/13). 
An absorber technique using polypropylene fleece, developed 
on the basis of findings by Ehmann et al. (25) was chosen for 
breath sampling. The sampling tubes dedicated for dog training 
and testing consisted of a glass tube (length: 150  mm, inner 
diameter: 18  mm) with GL25 sockets on both sides (Gaßner 
Glastechnik, Munich, Germany). Each tube was filled with two 
70  mm ×  43  mm polypropylene fleeces (Asota GmbH, Linz, 
Austria) (Figure  1). One was hydrophilically (Asota® olefin 
hydrophilic) and the other was hydrophobically (Asota® olefin 
hydrophob) modified. Tubes were closed with silicone septa for 
GL25 sockets (neoLab Migge Laborbedarf-Vertriebs GmbH, 
Heidelberg, Germany) and with polybutylene-terephthalate 
screw caps (Bohlender GmbH, Grünsfeld, Germany) (26, 27). 
During each breath sampling the volume of the airflow was 
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monitored with a spirometer (Ganshorn Medizin Medizin 
Electronic GmbH, Niederlauer, Germany). Each patient 
donated two fleece tube samples with a resting time of 10 min 
in between. Samples were stored refrigerated at 8°C until use. 
For dog training, 21 patient samples and 20 controls samples 
were used, 9 novel patient samples and 10 novel samples of 
controls were introduced for testing.
synthetic air samples
Humidified synthetic air (80% N2, 20% O2; relative humidity: 
84–89%) in a 1 L glass beaker with lateral septum as described 
in detail elsewhere (20) was spiked with 10 µL of a demineralized 
water solution containing 1-butanol (10.4  µg/L), 2-butanone 
(9.7 µg/L), 2-pentanone (3.2 µg/L), and hexanal (5.4 µg/L). The 
concentrations of the four compounds were chosen such that 
their concentrations in the glass bulb after injection through the 
septum were equal to the respective medians found in the breath 
of lung cancer patients in an observational study (20). After an 
equilibration period of 30  min, the air was transferred onto a 
fleece tube (see above) through a glass tube by means of an argon 
flow (160 mL/min for 30 min). Fleece tubes were closed tight and 
stored refrigerated at 8°C until use. A total of four fleece tubes 
loaded with spiked synthetic air were prepared.
Dog Training
All training was performed at the dog training and testing lab, 
Freie Universität Berlin. Four privately owned dogs were trained 
in this study, one 5-year-old spayed Labrador bitch, a 3-year-old 
intact female poodle, a 7-year-old female intact Dachshund, 
and an 8-year-old spayed Labrador Mix bitch. Selection was by 
convenience. Inclusion criteria were: dogs had to be clinically 
healthy, regularly available for training and familiar with training 
and testing of odor discrimination procedures (27).
In accordance with the European legislation (Dir. 2010/63/
EU), no animal was exposed to harmful conditions through-
out this study. During the study the dogs lived in their familiar 
home. The trainers had contributed to earlier odor detection 
studies with dogs (14, 28, 29). Training was conducted between 
June and December 2015–2016. The Labrador Mix and 
Dachshund did not make a considerable training progress in 
discriminating breath samples and were excluded from train-
ing after 3 months. Numbers of training days for the Labrador 
and the poodle were 73 and 82 days, respectively, with training 
trials (decision on a presented odor sample) ranging from 5 to 
20 (average 15) per training day. Training took place only once 
a week, dogs were not trained at the same time or same day.
Training methods were based on positive reinforcement 
using a clicker as a secondary reinforcement and small food 
treats as reward and dogs were off leash during training and 
testing. Every dog was rewarded with its favorite food. In case 
of a wrong indication, a reward was not given and the dog had 
to pause for at least 1 min before repeating the trial. The dogs 
were familiar with the sound of the clicker as a predictor for 
food. A minimum of 80% correct indications were required in 
order to progress to the next training step. In brief, the training 
approaches included following steps:
In the first step, a cone with a fleece tube sampled from a 
lung cancer patient as positive sample was presented to the dog, 
and the dog was immediately rewarded for sniffing the holder. 
The cone was standing on the floor approximately 1  m away 
from the dog. Then, the dog was trained to indicate the cone 
by standing still and pointing or sitting next to it. In step two, a 
second, empty cone was introduced and placed approximately 
50 cm away from the positive cone. The dog was required to 
identify and indicate the cone with the positive sample. In the 
third step, the second cone was loaded with a negative fleece 
tube sample (sampled from a healthy person) and the number 
of cones was increased to four (one positive, three negatives). 
Thus, the dog had to make a one-out-of-four decision (25% 
chance). After the dogs had performed a minimum of 80% 
correct indications, training was conducted in a double-blind 
manner. The dog handlers were not aware of the position of the 
positive sample and the experimenter was in a cubicle separated 
from the test room by a non-transparent curtain.
In the final training phase, number of positive cones per trial 
could vary from 0 to 4. When there was no positive in the trial, 
the dog was rewarded for returning to the handler after sniffing 
at all cones.
The perforated plate on top of a cone (positive or negative) 
was replaced whenever a dog’s nose had contact to it. Plates were 
cleaned in an ultrasonic bath for 90 s. The cones were wiped with 
a wet cloth to minimize the risk of scent contamination. Fleece 
tube samples were used multiple times and stored refrigerated at 
8°C in between training days.
Dog Testing
Dog testing took place in the same room as dog training. Two 
tests were performed in the scope of this study. The first test was 
to evaluate ability of the dogs’ to distinguish between sampled 
breath from cancer patients and healthy controls. In the second 
test, we included synthetic air samples spiked with 1-butanol, 
2-butanone, 2-pentanone, and hexanal. No sample used in train-
ing was used for the test.
For the first test, we used 9 cancer positive breath samples and 
10 samples from healthy controls. The samples were used up to 
three times. Each dog was presented with a total of 40 samples. 
We documented the reaction of the dogs at the first contact of the 
sample to avoid studying a memory effect.
The samples were presented in trials. Each trial consisted of 
2–4 cones presented to the dog. The cones were placed 40  cm 
apart from each other and at a distance of 2 m from the dog’s 
starting point. The number of cones with positive samples in one 
trial was random and could vary from 0 to 4.
Randomization both for samples within a trial and over 
all  trials occurred using the random number function of 
Excel  (Microsoft Office, Microsoft Cooperation, Redmond, 
WA, USA).
A positive indication varied between dogs and consisted of the 
dog in question either sitting down at the cone or standing still, 
nose pointing at the cone, for a minimum of 3 s. After a nega-
tive indication the dog moved on to the next cone. The handler 
announced each indication to the experimenter.
TaBle 3 | Indication (+ = correct; − = false) of dog at first contact with synthetic 
air samples with potential biomarker for lung cancer.
sample iD 1_DOT 2_DOT 3_DOT 4_DOT
Labrador + − + +
Poodle + + + −
TaBle 2 | Indication (+ = correct; − = false) of dog at first contact with breath 
sample of healthy probands.
sample iD 1515 1516 1517 1518 1519 7515 7516 7517 7518 7519
Labrador + + + + + + − + + −
Poodle − − − + − − − + + +
TaBle 1 | Indication (+ = correct; − = false) of dog at first contact with breath 
sample of patient suffering from lung cancer.
sample iD 1024 1025 1026 5074 5075 5076 5077 5078 5079
Labrador + + + + + + + + +
Poodle + + + − + + + + +
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In case of a correct positive indication, the dog was 
rewarded and the trial was finished. Cones the dogs had not 
sniffed remained in the lineup for the next trial, to make sure 
that dogs had to make decisions on every single cone. If the trial 
had no positive sample the dog was rewarded when it returned 
to the handler after sniffing all cones. Correct negative or false 
negative decisions were documented. Dog, handler, and any 
other person in the room were blinded to the position of the 
sample to avoid hidden clues.
In the second test, we wanted to observe the reaction of 
the dogs when they were presented with synthetic air samples. 
Therefore, 4 spiked synthetic air samples served as positive 
samples and all 10 healthy controls were included in the test. 
We presented 40 samples to the dogs. All synthetic air samples 
of the same composition, but different preparation days.
statistical Data analysis
The experimental set-up for breath samples with the random 
presentation of positive or negative samples led to the identifica-
tion of any sample as true positive, true negative, false positive, 
or false negative. In the second test, only breath samples from 
healthy probands served as controls but no synthetic control 
samples. Therefore, true negative rate was not calculated.
resUlTs
In the first test, the Labrador had a correct identification rate at 
first presentation of nine out of nine and the Poodle of eight out of 
nine. True negative rate was 8 out of 10 for the Labrador and 4 out 
of 10 for the poodle. Results are summarized in Tables 1 and 2.
In the second test with synthetic air sample, both dogs indi-
cated three out four synthetic samples as positive. Results for 
the first choice of the dog sniffing at the synthetic air samples 
are summarized in Table 3.
DiscUssiOn
In this study, two dogs were successfully trained to distinguish 
between breath samples from cancer patients and healthy con-
trols. During the course of the study, four adult dogs undertook 
training. Due to insufficient training progress, two dogs were 
excluded after 3 months of training.
With regard to similar studies, Elliker et al. (12) reported that 7 
out of 10 dogs in training were unable to reach the final stages of 
training. In the study of Gordon et al. (10), only 4 out of 10 dogs 
learnt to detect breast or prostate cancer in urine of human patients.
Due to the low number of dogs included in detection dog stud-
ies, it is difficult to prove an influence of the individual dog on the 
result statistically. We assume that some dogs have a higher ability 
to be trained for cancer detection than others. Further research 
is needed to identify selection criteria for the best possible cancer 
detection dog. Number of dogs in studies on cancer detection 
with dogs varies from 1 to 10 (28).
Unfortunately, only two dogs progressed to the final stage of 
training and could thus be included in the testing. While this is 
clearly an insufficient sample size, both dogs were able to indicate 
synthetic air samples as positive for cancer, which provides some 
proof of concept.
Our training duration of 16 months was long in comparison to 
shorter training periods described by other authors of 3 weeks (5), 
7 months (9), or 12 months (6). Frequency of training in our study 
was once a week, which may have led to the longer total training 
period required. Number of sample of probands was limited, so 
we had to use same samples for multiple training sessions. This 
bears the danger of teaching dogs the individual odor of these 
probands instead of the specific odor of cancer (4). For the test, 
we used 19 samples (9 positives and 10 negatives) of probands the 
dogs had no contact with before. For this reason, we only docu-
mented the reaction of the dogs at first contact with the samples.
Ability for distinguishing the probands is within the range of 
previous studies conducted on lung cancer detection by detection 
dogs. With regard to all articles published so far on canine detection 
of lung cancer in humans on the basis of breath odor, the mean sen-
sitivity was 78%, whereas the mean specificity was 71.5% (3). The 
results of the studies differ substantially. Whilst McCulloch et al. (5) 
found a sensitivity and specificity of 99% in detection of positive 
breath samples on lung cancer patients, the study by Amundsen 
et al. (11) revealed a mere 55.6% sensitivity and 8.3% specificity 
for small cell lung cancer. For a review of studies on lung cancer 
detection by detection dogs refer to Pirrone and Albertini (3).
The ability of the two dogs to discriminate breath samples was 
deemed satisfactory to continue with the project. The purpose 
of training the dogs to indicate breath samples of lung cancer 
patients was to test their response when they sniffed at synthetic 
air samples containing prospective VOCs that have previously 
been associated with lung cancer (20).
In the test to observe the reaction of dogs to synthetic air sam-
ples, both dogs indicated three out of four samples as cancer posi-
tive samples. Both dogs assigned the synthetic air samples to the 
cancer patients’ group. Our results suggest that dogs have potential 
be used to verify potential biomarkers for lung cancer. As a future 
perspective, this preliminary finding needs to be reproduced with 
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control samples spiked with substance with no potential for bio-
markers. As a next step genuine breath samples should be spiked 
with potential biomarkers and as controls with other substances 
found in breath samples not specific for cancer. Potential mislead-
ing of the dogs by unknown characteristics of involved genuine or 
spiked samples have to be ruled out by experimental design.
Lippi and Cervellin (30) suggested that, the “natural nose” of 
the animal might help to identify candidate biomarkers found 
by analytic technology. Buszewski et  al. (7) found a tendency 
of greater concentrations of butanal, 2-butanone, ethyl acetate, 
ethyl benzene, 2-pentanone, 1-propanol, and 2-propanol in the 
breath of 44 lung cancer patients in comparison to 29 controls. In 
addition, they trained dogs to distinguish between both groups 
with a sensitivity of 82.2% and specificity of 82.4%. They found 
that ethyl acetate and 2-pentanone correlated positively with the 
dogs’ positive indications. In a more recent study by this group 
with 108 lung cancer patients and 121 controls, including healthy 
probands and patients suffering from other lung diseases, a 
significant increase of concentrations of 1-propanol, 2-propanol, 
methyl acetate, hexanal, dimethyl sulfide, and carbon disulfide 
was found in the group of patients with lung cancer (31). With 
the help of Chi-squared automatic interaction detection, they 
were able to show that dimethyl sulfide is the main compound 
enabling differentiation between two groups: patients with cancer 
and healthy volunteers. They prepared synthetic samples on the 
basis of exhaled air of cancer patients. The indication of synthetic 
samples by the trained dogs was significantly worse (21%) than 
the indication of breath samples from cancer patients (86% cor-
rect positive). Unfortunately, the authors did not describe how 
the synthetic samples were prepared and which substances were 
included.
Based on the study by Schallschmidt et al. (20) we included 
1-butanol, 2-butanone, 2-pentanone, and hexanal in the synthetic 
air samples.
Although methods in these studies were different 2-butanone, 
2-pentanone, and hexanal were found throughout.
Currently available literature suggests that rather than there 
being one cancer-specific VOC, a combination of several VOCs 
display significantly higher concentrations in cancer patients 
(32). Buszewski et al. (7) stated that the signature odor of cancer 
that dogs use for differentiation between samples may be related 
to specific qualitative or quantitative olfactory impressions pro-
duced by a mixture of VOCs.
In this study, the two dogs discriminated the synthetic samples 
against healthy controls. In a more ideal test, it should be assessed 
if dogs discern between patients samples and synthetic samples, 
including VOCs potentially specific for cancer and VOCs not sus-
picious for cancer. This would underline the similarity between 
synthetic and patient samples.
Further research is warranted to test more combinations of 
potential biomarkers for lung cancer. We believe that specially 
trained detection dogs are a useful tool for finding the best pos-
sible biomarker for an effective diagnostic system for lung cancer.
eThics sTaTeMenT
The involvement of probands was approved by the Ethics 
Committee of the Charité, Berlin, Germany and registered as 
clinical trial with proof-of-concept (EA1/207/13).
aUThOr cOnTriBUTiOns
CF-T and IN were involved in study design, dog training (as well 
as DJ), and writing the manuscript. RB contributed substantially 
to the manuscript.
acKnOWleDgMenTs
Authors are indebted to W. Heuwieser (FU Berlin) for the help with 
the manuscript and to H. Schmutz (Evangelische Lungenklinik, 
Berlin) for valuable support with sampling and to Christian Jung 
(BAM) for the preparation of spiked samples.
FUnDing
This study was not funded through external sources.
reFerences
1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, 
Comber H, et  al. Cancer incidence and mortality patterns in Europe: esti-
mates for 40 countries in 2012. Eur J Cancer (2013) 49:1374–403. doi:10.1016/ 
j.ejca.2012.12.027 
2. Pomerantz A, Blachman-Braun R, Galnares-Olalde JA, Berebichez-Fridman 
R, Capurso-García M. The possibility of inventing new technologies in the 
detection of cancer by applying elements of the canine olfactory apparatus. 
Med Hypotheses (2015) 85:160–72. doi:10.1016/j.mehy.2015.04.024 
3. Pirrone F, Albertini M. Olfactory detection of cancer by trained sniffer 
dogs: a systematic review of the literature. J Vet Behave (2017) 19:105–17. 
doi:10.1016/j.jveb.2017.03.004 
4. Edwards TL, Browne CM, Schoon A, Cox C, Poling A. Animal olfactory 
detection of human diseases: guidelines and systematic review. J Vet Behave 
(2017) 20:59–73. doi:10.1016/j.jveb.2017.05.002 
5. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, 
Janecki T. Diagnostic accuracy of canine scent detection in early- and 
late-stage lung and breast cancers. Integr Cancer Ther (2006) 5:30–9. 
doi:10.1177/1534735405285096 
6. Horvath G, Jarverud GA, Jarverud S, Horvath I. Human ovarian car-
cinomas detected by specific odor. Integr Cancer Ther (2008) 7:76–80. 
doi:10.1177/1534735408319058 
7. Buszewski B, Ligor T, Jezierski T, Wenda-Piesik A, Walczak M, Rudnicka 
J. Identification of volatile lung cancer markers by gas chromatography-mass 
spectrometry: comparison with discrimination by canines. Anal Bioanal 
Chem (2012) 404:141–6. doi:10.1007/s00216-012-6102-8 
8. Ehmann R, Boedeker E, Friedrich U, Sagert J, Walles T, Friedel G. Detection 
of patients with lung cancer out of a risk group by breath sample presentation 
to sniffer dogs. Eur Respir J (2011) 39:669–76. 
9. Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, 
et al. Olfactory detection of human bladder cancer by dogs: proof of principle 
study. BMJ (2004) 329:712A–4A. doi:10.1136/bmj.329.7477.1286-a 
10. Gordon RT, Schatz CB, Myers LJ, Kosty M, Gonczy C, Kroener J, et al. The use 
of canines in the detection of human cancers. J Altern Complement Med (2008) 
14:61–7. doi:10.1089/acm.2006.6408 
11. Amundsen T, Sundstrom S, Buvik T, Gederaas OA, Haaverstad R. Can dogs 
smell lung cancer? First study using exhaled breath and urine screening in 
unselected patients with suspected lung cancer. Acta Oncol (2014) 53:307–15. 
doi:10.3109/0284186X.2013.819996 
6Fischer-Tenhagen et al. Seaching Biomarker for Cancer With Dogs
Frontiers in Veterinary Science | www.frontiersin.org March 2018 | Volume 5 | Article 52
12. Elliker KR, Sommerville BA, Broom DM, Neal DE, Armstrong S, Williams HC. 
Key considerations for the experimental training and evaluation of cancer odour 
detection dogs: lessons learnt from a double-blind, controlled trial of prostate 
cancer detection. BMC Urol (2014) 14:22. doi:10.1186/1471-2490-14-22 
13. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, et  al. 
TD-GC-MS analysis of volatile metabolites of human lung cancer and 
normal cells in  vitro. Cancer Epidemiol Biomarkers Prev (2010) 19:182–95. 
doi:10.1158/1055-9965.EPI-09-0162 
14. Schallschmidt K, Becker R, Zwaka H, Menzel R, Johnen D, Fischer-
Tenhagen C, et  al. In vitro cultured lung cancer cells are not suitable for 
animal-based breath biomarker detection. J Breath Res (2015) 9:027103. 
doi:10.1088/1752-7155/9/2/027103 
15. Matsumura K, Opiekun M, Oka H, Vachani A, Albelda SM, Yamazaki K, 
et al. Urinary volatile compounds as biomarkers for lung cancer: a proof of 
principle study using odor signatures in mouse models of lung cancer. PLoS 
One (2010) 5:8819. doi:10.1371/journal.pone.0008819 
16. Poli D, Goldoni M, Corradi M, Acampa O, Carbognani P, Internullo E, et al. 
Determination of aldehydes in exhaled breath of patients with lung cancer by 
means of on-fibre-derivatisation SPME-GC/MS. J Chromatogr B Analyt Technol 
Biomed Life Sci (2010) 878:2643–51. doi:10.1016/j.jchromb.2010.01.022 
17. Filipiak W, Filipiak A, Sponring A, Schmid T, Zelger B, Ager C, et al. Comparative 
analyses of volatile organic compounds (VOCs) from patients, tumors and 
transformed cell lines for the validation of lung cancer-derived breath mark-
ers. J Breath Res (2014) 8:027111. doi:10.1088/1752-7155/8/2/027111 
18. Fuchs P, Loeseken C, Schubert JK, Miekisch W. Breath gas aldehydes as 
biomarkers of lung cancer. Int J Cancer (2010) 126(11):2663–70. doi:10.1002/
ijc.24970
19. Ulanowska A, Kowalkowski T, Trawińska E, Buszewski B. The application of 
statistical methods using VOCs to identify patients with lung cancer. J Breath 
Res (2011) 5(4):046008. doi:10.1088/1752-7155/5/4/046008
20. Schallschmidt K, Becker R, Jung C, Bremser W, Walles T, Neudecker J, et al. 
Comparison of volatile organic compounds from lung cancerbpatients and 
healthy controls—challenges and limitations of an observational study. 
J Breath Res (2016) 10:046007. doi:10.1088/1752-7155/10/4/046007 
21. Guadagni R, Miraglia N, Simonelli A, Silvestre A, Lamberti M, Feola D, 
et al. Solid-phase microextraction–gas chromatography–mass spectrometry 
method validation for the determination of endogenous substances: urinary 
hexanal and heptanal as lung tumor biomarkers. Anal Chim Acta (2011) 
701:29–36. doi:10.1016/j.aca.2011.05.035 
22. Deng C, Zhang X, Li N. Investigation of volatile biomarkers in lung cancer 
blood using solid-phase microextraction and capillary gas chromatography- 
mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 
808:269–77. 
23. Song G, Qin T, Liu H, Xu GB, Pan YY, Xiong FX, et al. Quantitative breath 
analysis of volatile organic compounds of lung cancer patients. Lung Cancer 
(2010) 67:227–31. doi:10.1016/j.lungcan.2009.03.029 
24. Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Klieber M, et  al. 
Determination of volatile organic compounds in exhaled breath of patients 
with lung cancer using solid phase microextraction and gas chromatography 
mass spectrometry. Clin Chem Lab Med (2009) 47:550–60. doi:10.1515/ 
CCLM.2009.133 
25. Ehmann R, Boedeker E, Friedrich U, Sagert J, Walles T, Friedel G. 
Detection of patients with lung cancer out of a risk group by breath 
sample presentation to sniffer dogs. Eur Respir J (2011) 39:669–76. 
doi:10.1183/09031936.00051711 
26. Schallschmidt K. Biomarker in Atemluft – Qualitätsgesicherte 
Methodenentwicklung für die Biomarkeridentifizierung zur nicht-invasiven 
Lungenkrebsdiagnose. Dissertation Thesis, Humboldt Universität zu Berlin, 
Berlin, Germany (2017).
27. Fischer-Tenhagen C, Johnen D, Heuwieser W, Becker R, Schallschmid K, 
Nehls I. Odor perception by dogs: evaluating two training approaches for 
odor learning of sniffer dogs. Chem Senses (2017) 42:435–41. doi:10.1093/
chemse/bjx020 
28. Johnen D, Heuwieser W, Fischer-Tenhagen C. Canine scent detection—
fact or fiction? Appl Anim Behav Sci (2013) 148:201–8. doi:10.1016/ 
j.applanim.2013.09.002 
29. Fischer-Tenhagen C, Tenhagen BA, Heuwieser W. Short communication: 
Ability of dogs to detect cows in estrus from sniffing saliva samples. J Dairy 
Sci (2013) 96:1081–4. doi:10.3168/jds.2012-5683
30. Lippi G, Cervellin G. Canine olfactory detection of cancer versus labora-
tory testing: myth or opportunity? Clin Chem Lab Med (2012) 50:435–9. 
doi:10.1515/CCLM.2011.672
31. Rudnicka J, Walczak M, Kowalkowski T, Jezierski T, Buszewski B. 
Determination of volatile organic compounds as potential markers of lung 
cancer by gas chromatography–mass spectrometry versus trained dogs. Sens 
Actuators B Chem (2014) 202:615–21. doi:10.1016/j.snb.2014.06.006 
32. Jezierski T, Walczak M, Ligor T, Rudnicka J, Buszewski B. Study of the 
art: canine olfaction used for cancer detection on the basis of breath 
odour. Perspectives and limitations. J Breath Res (2015) 9:027001. 
doi:10.1088/1752-7155/9/2/027001 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Fischer-Tenhagen, Johnen, Nehls and Becker. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (CC 
BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) and the copyright owner are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. 
No use, distribution or reproduction is permitted which does not comply with these 
terms.
